Bionovate Technologies Corp
$0.00+0.00%(+$0.00)
TickerSpark Score
47/100
80
Valuation
45
Profitability
60
Growth
20
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIIO research report →
52-Week Range50% of range
Low $0.00
Current $0.00
High $0.00
Companybionovate.com
Bionovate Technologies Corp. , a medical device company, focuses on developing automated treatment for age spots. It intends to develop automated computerized system that treats age spots anywhere on the body.
- CEO
- Timothy Jones
- IPO
- 2014
- HQ
- Cham, CH
Price Chart
+0.00% · this period
Valuation
- Market Cap
- $775
- P/E
- -0.01
- P/S
- 0.00
- P/B
- -0.00
- EV/EBITDA
- -5.25
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 23.68%
- ROIC
- 17.07%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-106,544 · 12.70%
- EPS
- $-0.00 · 51.02%
- Op Income
- $-45,371
- FCF YoY
- -331.37%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 8.96
- Avg Volume
- 13
Get TickerSpark's AI analysis on BIIO
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BIIO Coverage
We haven't published any research on BIIO yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BIIO Report →